vs

Side-by-side financial comparison of BrightSpire Capital, Inc. (BRSP) and GLAUKOS Corp (GKOS). Click either name above to swap in a different company.

GLAUKOS Corp is the larger business by last-quarter revenue ($150.6M vs $83.2M, roughly 1.8× BrightSpire Capital, Inc.). GLAUKOS Corp runs the higher net margin — 6.2% vs -17.3%, a 23.5% gap on every dollar of revenue. On growth, GLAUKOS Corp posted the faster year-over-year revenue change (41.2% vs -0.4%). Over the past eight quarters, GLAUKOS Corp's revenue compounded faster (25.4% CAGR vs -6.8%).

Oakley Capital Investments, is a large British investment trust focused on investments in mid-market companies in the business services, consumer, education and technology sectors. The company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.

BRSP vs GKOS — Head-to-Head

Bigger by revenue
GKOS
GKOS
1.8× larger
GKOS
$150.6M
$83.2M
BRSP
Growing faster (revenue YoY)
GKOS
GKOS
+41.5% gap
GKOS
41.2%
-0.4%
BRSP
Higher net margin
GKOS
GKOS
23.5% more per $
GKOS
6.2%
-17.3%
BRSP
Faster 2-yr revenue CAGR
GKOS
GKOS
Annualised
GKOS
25.4%
-6.8%
BRSP

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BRSP
BRSP
GKOS
GKOS
Revenue
$83.2M
$150.6M
Net Profit
$-14.4M
$9.4M
Gross Margin
77.9%
Operating Margin
9.0%
Net Margin
-17.3%
6.2%
Revenue YoY
-0.4%
41.2%
Net Profit YoY
27.3%
EPS (diluted)
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BRSP
BRSP
GKOS
GKOS
Q1 26
$150.6M
Q4 25
$83.2M
$143.1M
Q3 25
$83.9M
$133.5M
Q2 25
$85.9M
$124.1M
Q1 25
$77.6M
$106.7M
Q4 24
$83.5M
$105.5M
Q3 24
$88.2M
$96.7M
Q2 24
$91.4M
$95.7M
Net Profit
BRSP
BRSP
GKOS
GKOS
Q1 26
$9.4M
Q4 25
$-14.4M
$-133.7M
Q3 25
$984.0K
$-16.2M
Q2 25
$-23.1M
$-19.7M
Q1 25
$5.3M
$-18.1M
Q4 24
$-19.7M
$-33.6M
Q3 24
$12.7M
$-21.4M
Q2 24
$-67.9M
$-50.5M
Gross Margin
BRSP
BRSP
GKOS
GKOS
Q1 26
77.9%
Q4 25
-1.1%
Q3 25
78.4%
Q2 25
78.3%
Q1 25
77.2%
Q4 24
72.9%
Q3 24
76.6%
Q2 24
76.4%
Operating Margin
BRSP
BRSP
GKOS
GKOS
Q1 26
9.0%
Q4 25
-97.7%
Q3 25
-1.7%
-12.3%
Q2 25
-54.5%
-18.3%
Q1 25
5.1%
-19.4%
Q4 24
-24.9%
-27.2%
Q3 24
13.2%
-25.5%
Q2 24
-74.9%
-31.3%
Net Margin
BRSP
BRSP
GKOS
GKOS
Q1 26
6.2%
Q4 25
-17.3%
-93.4%
Q3 25
1.2%
-12.2%
Q2 25
-26.9%
-15.8%
Q1 25
6.9%
-17.0%
Q4 24
-23.7%
-31.8%
Q3 24
14.4%
-22.1%
Q2 24
-74.2%
-52.8%
EPS (diluted)
BRSP
BRSP
GKOS
GKOS
Q1 26
Q4 25
$-0.11
$-2.34
Q3 25
$0.00
$-0.28
Q2 25
$-0.19
$-0.34
Q1 25
$0.04
$-0.32
Q4 24
$-0.16
$-0.56
Q3 24
$0.09
$-0.39
Q2 24
$-0.53
$-1.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BRSP
BRSP
GKOS
GKOS
Cash + ST InvestmentsLiquidity on hand
$66.8M
$276.7M
Total DebtLower is stronger
$2.5B
Stockholders' EquityBook value
$938.4M
$670.9M
Total Assets
$3.6B
$893.3M
Debt / EquityLower = less leverage
2.63×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BRSP
BRSP
GKOS
GKOS
Q1 26
$276.7M
Q4 25
$66.8M
$90.8M
Q3 25
$113.4M
$98.2M
Q2 25
$154.3M
$100.8M
Q1 25
$200.9M
$114.3M
Q4 24
$302.2M
$169.6M
Q3 24
$263.8M
$100.1M
Q2 24
$203.3M
$68.1M
Total Debt
BRSP
BRSP
GKOS
GKOS
Q1 26
Q4 25
$2.5B
Q3 25
$2.2B
Q2 25
$2.3B
Q1 25
$2.3B
Q4 24
$2.5B
Q3 24
$2.6B
Q2 24
$2.5B
Stockholders' Equity
BRSP
BRSP
GKOS
GKOS
Q1 26
$670.9M
Q4 25
$938.4M
$656.2M
Q3 25
$976.4M
$769.5M
Q2 25
$994.4M
$765.1M
Q1 25
$1.0B
$764.0M
Q4 24
$1.0B
$766.9M
Q3 24
$1.1B
$668.5M
Q2 24
$1.1B
$665.2M
Total Assets
BRSP
BRSP
GKOS
GKOS
Q1 26
$893.3M
Q4 25
$3.6B
$893.5M
Q3 25
$3.3B
$999.4M
Q2 25
$3.4B
$987.0M
Q1 25
$3.6B
$966.2M
Q4 24
$3.7B
$974.8M
Q3 24
$3.8B
$926.5M
Q2 24
$3.8B
$919.7M
Debt / Equity
BRSP
BRSP
GKOS
GKOS
Q1 26
Q4 25
2.63×
Q3 25
2.22×
Q2 25
2.27×
Q1 25
2.27×
Q4 24
2.38×
Q3 24
2.36×
Q2 24
2.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BRSP
BRSP
GKOS
GKOS
Operating Cash FlowLast quarter
$73.0M
Free Cash FlowOCF − Capex
$55.1M
FCF MarginFCF / Revenue
66.2%
Capex IntensityCapex / Revenue
21.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$102.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BRSP
BRSP
GKOS
GKOS
Q1 26
Q4 25
$73.0M
$6.8M
Q3 25
$29.9M
$-10.1M
Q2 25
$17.4M
$7.0M
Q1 25
$10.5M
$-18.5M
Q4 24
$103.4M
$507.0K
Q3 24
$31.3M
$-9.6M
Q2 24
$22.9M
$-18.4M
Free Cash Flow
BRSP
BRSP
GKOS
GKOS
Q1 26
Q4 25
$55.1M
$3.9M
Q3 25
$27.4M
$-11.7M
Q2 25
$11.6M
$5.8M
Q1 25
$8.0M
$-20.5M
Q4 24
$97.3M
$-1.2M
Q3 24
$28.3M
$-11.0M
Q2 24
$22.7M
$-20.5M
FCF Margin
BRSP
BRSP
GKOS
GKOS
Q1 26
Q4 25
66.2%
2.7%
Q3 25
32.7%
-8.8%
Q2 25
13.4%
4.7%
Q1 25
10.3%
-19.2%
Q4 24
116.6%
-1.2%
Q3 24
32.1%
-11.4%
Q2 24
24.9%
-21.4%
Capex Intensity
BRSP
BRSP
GKOS
GKOS
Q1 26
Q4 25
21.6%
2.0%
Q3 25
2.9%
1.2%
Q2 25
6.8%
0.9%
Q1 25
3.2%
1.8%
Q4 24
7.3%
1.6%
Q3 24
3.4%
1.5%
Q2 24
0.1%
2.2%
Cash Conversion
BRSP
BRSP
GKOS
GKOS
Q1 26
Q4 25
Q3 25
30.36×
Q2 25
Q1 25
1.97×
Q4 24
Q3 24
2.46×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons